Krystal Biotech, Inc.

#EpidermolysisBullosa is a group of rare genetic skin disorders that cause the skin to become very fragile and blister easily. Those with EB are known as "butterflies" as their skin is as fragile as butterfly wings. Learn more this #EBAwarenessWeek2024 at debra-international.org

The Krystal Biotech team was proud to attend debra of America's gala event on Saturday as a part of EB Awareness Week.

Today begins #EBAwarenessWeek - spread awareness about EB, a rare skin disease that causes extremely fragile skin that blisters and tears with any friction. Learn more and show support of #EBAwarenessWeek from Oct 25-31: https://krys.bio/gs7

September 15 through October 15 marks #HispanicAmericanHeritageMonth, a time to commemorate the histories, cultures and contributions of those with Hispanic heritage living in the U.S. At Krystal, we would like to recognize and appreciate this month, and all year long, the many contributions of Hispanic Americans to American life. #HispanicAmericanHeritageMonth

Krystal Biotech was proud to attend the EBMRF’s Rock4EB event and connect with the EB community! #EpidermolysisBullosa

Today is World Cystic Fibrosis Day. #CF is an inherited, chronic disease that interferes with the function of the respiratory, digestive and reproductive systems. Mutations in the CFTR gene affect the balance of salt and water in cells lining the lung, pancreas, and other organs, leading to build up of thick, sticky mucus. Join #KrystalBio to raise awareness & support all those managing CF. #CysticFibrosis #RareDiseaseAwareness

Last Wednesday, Jeune Aesthetics shared Phase 1 positive interim safety and efficacy results for their lead product, KB301, in the treatment of lateral canthal lines at rest and dynamic wrinkles of the décolleté. Listen to the webcast here: https://krys.bio/nve #dermatology #MedicalAesthetics #GeneticAesthetics

Today we celebrate the hard work, passion, & accomplishments of our incredible team at Krystal. Every employee’s dedication makes a genuine difference in our patients' lives. #HappyLaborDay

Jeune and Krystal will host a webcast today, Wednesday, 8/28/24 at 4:30 PM ET, to discuss the positive interim efficacy & safety results from the Phase 1 study evaluating lead program KB301, Jeune’s pipeline product candidates, and the strategic vision for Jeune. Join the webcast here: https://krys.bio/nve

News: Krystal's subsidiary Jeune Aesthetics announces Phase 1 positive interim safety and efficacy results for KB301 in the treatment of lateral canthal lines at rest and dynamic wrinkles of the décolleté. Read more: https://krys.bio/8w0 #dermatology #MedicalAesthetics #GeneticAesthetics